Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises the sellers in connection with the divestment of Johan i Hallen & Bergfalk
Mandate

Vinge advises the sellers in connection with the divestment of Johan i Hallen & Bergfalk

May 04, 2023 Banking and Finance M&A

Vinge advises the sellers, represented by Litorina V Fund, in connection with the divestment of JOHBECO AB (including its Swedish and Finnish subsidiaries Johan i Hallen & Bergfalk) to METRO FSD Holding GmbH, an indirect subsidiary of international wholesaler METRO AG.

Johan i Hallen & Bergfalk operates on the Swedish and Finnish markets and is a leading Swedish specialist provider of high quality fresh proteins such as meat, fish and seafood to restaurants, hotels and cafés.

Vinge’s team consisted of Jonas Johansson, Carl Sander, Desirée Hagenfeldt and Robin Sultani (M&A) and Karl-Gustaw Tobola (Bank & Financing) as well as Julia Hagelberg, Emy Rydén and Anna Ekdahl Roos (project assistants).

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025